The Steven & Alexandra Cohen Foundation Grants More than $2.1 Million to Support a Psychedelics Research Study at Mount Sinai

The Center for Psychedelic Psychotherapy and Trauma Research in the Department of Psychiatry at Mount Sinai today announced a $2.1 million charitable contribution by the Steven & Alexandra Cohen Foundation.

Mount Sinai Researchers Develop Novel Therapy That Could Be Effective in Many Cancers

Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July.

Mount Sinai Research Reveals How the Ebola Virus Manages to Evade the Body’s Immune Defenses

Mount Sinai researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention. In a study published in mBio, the team reported how a protein of the Ebola virus, VP24, interacts with the double-layered membrane of the cell nucleus (known as the nuclear envelope), leading to significant damage to cells along with virus replication and the propagation of disease.

Mount Sinai Welcomes Robotic Prostate Surgery Pioneer Mani Menon, MD

Robotic prostate surgery pioneer Mani Menon, MD, is joining Mount Sinai and will serve as Chief of Strategy and Innovation in the Department of Urology for the Mount Sinai Health System. He will also serve as a Professor of Urology, Director of Education and Director of the Precision Prostatectomy Program in the Department of Urology at Icahn Mount Sinai and Center of Excellence for Prostate Cancer at The Tisch Cancer Institute.

Mount Sinai Leaders Discuss Equity, the Impact of the Pandemic on Healthcare, and the Unprecedented Era and Increasing Interest of Psychedelics on Treating Mental Health at the 2021 Aspen Ideas Health and Aspen Ideas Festival

Reflections on the pandemic, developing innovative solutions to address inequities in health and medicine, and the use of psychedelic drugs to help treat psychiatric disorders are among the topics presented at Aspen Ideas Health and the Aspen Ideas Festival from June 27-July 1, 2021, in Aspen, Colorado. Presented by the Aspen Institute and sponsored by the Mount Sinai Health System, the festival is a unique forum for the exchange of ideas.

Mount Sinai’s Simulation Teaching and Research Center Earns Four Accreditations From Society for Simulation in Healthcare

Only center in the world with this combination of distinctions

The Mount Sinai Hospital Recognized as No. 4 on Newsweek’s World’s Best Smart Hospital 2021 List

The Mount Sinai Hospital is ranked No. 1 in the New York City metropolitan area and No. 4 globally among the most technologically advanced health care institutions on Newsweek’s list of “The World’s Best Smart Hospitals 2021.”

Internationally Renowned Breast Cancer and HIV-Associated Malignancy Expert to Join Mount Sinai

Mount Sinai Health System has recruited an internationally recognized expert in the management of breast cancer and HIV-associated malignancies, Joseph A. Sparano, MD, FACP, as Chief of Hematology and Medical Oncology and Deputy Director of The Tisch Cancer Institute (TCI). Dr. Sparano will also hold the Ezra M. Greenspan, MD Professorship in Clinical Cancer Therapeutics at the Icahn School of Medicine at Mount Sinai and will oversee the expansion of clinical and research capacities of the Division and TCI.

Two Mount Sinai Leaders Receive Prestigious Honors from American Heart Association in New York City

Two of Mount Sinai’s top doctors will be honored with prestigious awards at the American Heart Association’s New York City Heart and Stroke Ball, taking place virtually on Wednesday, June 9.

High Caffeine Consumption may be Associated with Increased Risk of Blinding Eye Disease

Frequent caffeine intake could more than triple risk of glaucoma for those genetically predisposed to higher eye pressure

Mount Sinai identifies the causes of racial disparity in prostate cancer in a multi-institutional study

MEDIA ADVISORY Senior Author:  Ash Tewari, MBBS, MCh, Professor and System Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai and Director of the Center of Excellence for Prostate Cancer…

A Technique for Regulating Emotion May be Effective in Disrupting Compulsive Cocaine Addiction, a Mount Sinai Study Has Found

An emotion regulation strategy known as cognitive reappraisal helped reduce the typically heightened and habitual attention to drug-related cues and contexts in cocaine-addicted individuals, a study by Mount Sinai researchers has found.

Fat Around the Heart Linked to Increased Risk of Heart Failure

EMBARGOED UNTIL MAY 24 2:00PM EST (New York, NY – May 24, 2021) – Having excess pericardial fat—fat around the heart—increases the risk of developing heart failure, especially in women, according to new Mount Sinai research. Women with high amounts…

Mount Sinai Cardiovascular Doctors to Receive Honors During American College of Cardiology 70th Annual Scientific Session

William Whang, MD, Associate Professor of Medicine (Cardiology), and Gilbert Tang, MD, MSc, MBA, Associate Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, are receiving the 2021 Simon Dack Awards for their exceptional contributions to the Journal of the American College of Cardiology (JACC).

Study Shows Significant Reduction in Triglycerides in Patients at High Risk for Acute Pancreatitis Through Novel Monoclonal Antibody

The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai

Mount Sinai Ophthalmologists Develop New Technique to Assess Progression of Sickle Cell Retinopathy

(New York, NY – May 10, 2021)- Ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai have created a new technique to evaluate patients with sickle cell retinopathy and assess the disease before it progresses and leads to…

Biopreparedness Expert Gustavo Palacios, PhD, to Join Mount Sinai, Strengthening Research Collaborations with Department of Defense

Virologist Gustavo Palacios, PhD, is joining the Icahn School of Medicine at Mount Sinai from the United States Army Medical Research Institute of Infectious Diseases (USAMRIID), where he led the application and development of molecular epidemiology to advance the field of biopreparedness. Dr. Palacios will strengthen existing research collaborations between Icahn Mount Sinai and the United States Army-Department of Defense (DoD), laying a foundation for joint research initiatives to protect national and global public health.

Mount Sinai Department of Surgery Launches Program to Combat Burnout and Manage Stress Among Surgical Faculty, Trainees & Staff

Recognizing that burnout and stress have a negative impact on the personal and professional lives of faculty, staff, and trainees, as well as the quality of care that patients receive, the Mount Sinai Department of Surgery has launched the Stress Intervention Tools (SIT) program to help surgeons work through their emotions, reduce their anxiety, and manage crises.

Mount Sinai Health System Celebrates Nurses Week

In honor of Nurses Week, Thursday, May 6, through Wednesday, May 12, Mount Sinai Health System will host several celebratory and commemorative events to celebrate the professionalism, innovation, and resilience of nurses. The events will highlight and showcase the great work of Mount Sinai nurses during this pandemic and beyond, underscoring the importance and prominence of their role in health care.

Oula Announces Hospital Partnership with Mount Sinai West for Deliveries

Oula, a modern maternity center combining the best of obstetrics and midwifery care, today announced its partnership with Mount Sinai West, one of New York’s well-respected hospitals, located on the west side of Manhattan. Through this partnership, Oula patients — who receive prenatal, birth, and postpartum care via the company’s collaborative medical team, Brooklyn clinic, and remote care platform — will now be able to deliver their babies at Mount Sinai. They will receive full access to hospital resources and specialists they may need, all while remaining under the care of Oula’s medical team for non-surgical births.

$10 Million Gift to Open the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai

With highly trained specialists skilled in caring for different types of melanoma, patients at the Waldman Melanoma and Skin Center will have access to the newest diagnostics and therapies such as Canfield Vectra180 – a 3D whole body imaging system that captures nearly the entire skin surface in macro quality resolution, and will be able to capture early skin cancer lesions; Nevisense—a safe diagnostic support tool utilizing Electrical Impedence Spectroscopy (EIS) which is applied as a harmless electrical signal to the skin; Vivascope 1500—a non-invasive confocal imaging system which offers a non-invasive way to image the skin to the superficial collagen layers; and innovative technologies which non-invasively collects skin cells through adhesive patches rather than a scalpel to diagnose atypical pigmented lesions (or moles) at high risk for melanoma.

Mount Sinai Study Finds That Blood Clotting Drug Commonly Used for Orthopedic Surgeries Does Not Increase Complications for High-Risk Patients

Mount Sinai Researchers Find That Tranexamic Acid, a Blood Clotting Drug Commonly Used for Orthopedic Surgeries, Does Not Increase Complications for High-Risk Patients

Genetic Ancestry Versus Race Can Provide Specific, Targeted Insights to Predict and Treat Many Diseases

The complex patterns of genetic ancestry uncovered from genomic data in health care systems can provide valuable insights into both genetic and environmental factors underlying many common and rare diseases, according to a team of Mount Sinai researchers.

Mount Sinai researchers discover multiple types of DNA methylation from individual bacteria and microbiome using nanopore sequencing

MEDIA ADVISORY   – UNDER EMBARGO UNTIL Monday, April 5 at 11:00 AM EST Journal Name:  Nature Methods Title of the Article: Discovering multiple types of DNA methylation from individual bacteria and microbiome using nanopore sequencing Corresponding Author:  Gang Fang, PhD…

Removal of AKAP11 Protein by Autophagy as a Key to Fuel Mitochondrial Metabolism and Tumor Cell Growth Through Activating Protein Kinase A (PKA)

MEDIA ADVISORY   FOR IMMEDIATE RELEASE: Proceedings of the National Academy of Sciences of the United States (PNAS) Published Online on March 30, 2021 Mount Sinai Researchers Find “Removal of AKAP11 protein by autophagy as a key to fuel mitochondrial metabolism and…

Liver Cancer Tumors Appear to Be Resistant to Immunotherapy in Patients With Underlying Non-alcoholic Steatohepatitis (NASH)

Immunotherapy is not only significantly less effective in liver cancer patients who previously had a liver disease called non-alcoholic steatohepatitis (NASH), but actually appears to fuel tumor growth, according to a Mount Sinai study published in Nature in March. NASH affects as many as 40 million people worldwide and is associated with obesity and diabetes.

Mount Sinai Scientists Discover an Epigenetic Mechanism Contributing to Lifelong Stress Susceptibility

An epigenetic modification that occurs in a major cell type in the brain’s reward circuitry controls how stress early in life increases susceptibility to additional stress in adulthood, researchers at the Icahn School of Medicine at Mount Sinai have learned.

Mount Sinai Researchers Find that a Second Shot of COVID-19 Vaccine May Not be Necessary in Previously Infected Individuals

A single shot of one of the currently authorized COVID-19 vaccines may be sufficient to provide immunity to individuals who have previously been infected by the virus, thus eliminating the need for a second dose and helping to stretch severely limited vaccine supplies, a study from Mount Sinai has found

Mount Sinai Venture Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021

Mount Sinai Health System announced today that Kantaro Biosciences, LLC, a joint venture with RenalytixAI, has been named to Fast Company’s prestigious annual list of the “World’s Most Innovative Companies” for 2021 and ranked first in the Joint Ventures category.

Nicotinic regulation of local and long-range input balance drives top-down attentional circuit maturation

MEDIA ADVISORY – FOR IMMEDIATE RELEASE  Published March 5, 2021 in Science Advances Mount Sinai Researchers find a new way to prevent attention deficits associated with Fragile X, a leading genetic cause of autism, in an animal model. Corresponding Author:  Hirofumi…

Mount Sinai Researchers Identify Mechanisms That Are Essential for Proper Skin Development

Mount Sinai researchers have discovered that Polycomb complexes, groups of proteins that maintain gene expression patterns, are essential for proper skin development, according to a paper published in Genes & Development on February 18.